On 28/03/2019, the Ministry of Health issued Circular No. 03/2019/TT-BYT on the List of domestically produced medicines to meet the requirements of treatment, drug prices and supply capacity. This Circular takes effect from 01/06/2019.
Accordingly, Circular No. 03/2019/TT-BYT has listed 640 domestically produced drugs to meet the requirements for treatment, drug prices and supply capacity. Details in the list of domestically produced drugs meet the requirements for treatment, drug prices and availability.
Thus, Circular 03/2019/TT-BYT plays an important role in determining the types of drugs offered for bidding. Because the bidding documents of the medical establishments must clearly state that the bid for imported drugs with the same technical criteria cannot be offered with the drugs included in the List of Circular 03/2019 / TT-BYT.
Bidding for imported drugs can only be made in case the Ministry of Health issues a decision to permit the bid for imported drugs for a certain period of time because of the sudden increase in demand for drugs and medical facilities.